Zinc sulphate following the administration of iodine-131 on the regulation of thyroid function, in rats

Hellenic Journal of Nuclear Medicine

Volumn 10, Issue 3, 2007, Pages 167-171

  Dhawan, Davinder ^a   Baweja, Mandeep Singh ^a   Dani, Vijayta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Iodine 131; Radioprotection; Stable zinc sulphate; Thyroid nonspecific functions

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); IODINE 131; LIOTHYRONINE; THYROTROPIN; THYROXINE; ZINC SULFATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; IODINE 131 UPTAKE TEST; LIOTHYRONINE BLOOD LEVEL; NONHUMAN; RADIATION PROTECTION; RAT; THYROID FOLLICLE CELL; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WISTAR RAT;

ANIMALS; FEMALE; HYPOTHYROIDISM; IODIDE PEROXIDASE; IODINE RADIOISOTOPES; KINETICS; OVARIAN FOLLICLE; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; THYROID FUNCTION TESTS; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE; ZINC SULFATE;

EID: 37849024947     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cooper DS. Radioiodine for hyperthyroidism. Where do we stand after 50 years? JAMA 1998; 280: 375-376.
2. 131I treatment of nodular non-toxic goiter. Eur J Endocrinol 1996; 134: 15-20.
3. Nygaard B, Hegedus L, Ulriksen P et al. Radioiodine therapy for multinodular toxic goiter. Arch Inteen Med 1999; 159: 1364-1368.
4. Hermus A, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 338: 1438-1447.
5. Leech NJ, Dayan CM. Controversies in the management of Grave's disease. Clin Endocrinol 1998; 49: 273-280.
6. Kendall-Taylor P, Keir MJ, Ross WM. Ablative radioiodine therapy hyperthyroidism. Br Med J 1984; 289: 361-363.
7. Alexander C, Bader JB, Schaefer A et al. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med 1998; 39: 1551-1554.
8. 125I isotopes of iodine in the rat. J Endocrinol, 1976; 71: 109-114
9. Dhawan D, Sharma RR, Sharma R, Dash RJ. Effect of short-term and long-term lithium treatment on uptake and retention of iodine-131 in rat thyroid. Aust J Biol Sci 1988; 41: 387-392.
10. Prasad AS. Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nutr Rev 1983; 41: 197-208.
11. McCall KA, Huang C, Fierke CA. Function and mechanism of zinc metalloenzymes. J Nutr 2000; 130: 1437S-1446S.
12. Coyle P, Philcox JC, Carey LC, Role AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002; 59: 627-647.
13. Kadrobova J, Madaric A, Sustrova M, Ginter E. Changed serum element profile in Down's syndrome. Biol Trace Elem Res 1996; 54: 201-206.
14. Dhawan D, Goel A. Further evidence for zinc as a hepatoprotective agent in rat liver toxicity. Exp Mol Pathol 1996; 63: 110-117.
15. Colvard DS, Wilson EM. Zinc potentiation of androgen receptor binding to nuclei in vitro. Biochemistry 1984; 23: 3471-3478.
16. Ramirez IJ, Halwer M, Shapiro LE, Surks MI. Zinc (II) inhibits the release of thyroid and glucocorticoid receptors from chromatin of cultured C-cells. Horm Metab Res 1991; 23: 155-161.
17. 4 levels and hepatic functions in carbontetrachloride-intoxicated rats. Biol Trace Elem Res 1994; 41: 59-68.
18. Sustrova M, Strbak V. Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy. J Endocrinol Invest 1994; 17: 385-390.
19. Bucci I, Napolitano G, Giuliani C. Zinc sulphate supplementation improves thyroid function in hypozincemics Down children. Biol Trace Elem Res 1999; 67: 257-268.
20. Vijayta D, Dhawan DK. Radioprotective role of zinc following single dose radioiodine-131 exposure to red blood cells of rats. Indian J of Med Res. 2005; 122: 338-342.
21. 99mTc-mebrofenin in protein deficient and lead toxicant rats. Hell J Nucl Med 2002; 2: 118-122.
22. Sidhu P, Garg ML, Dhawan DK. Protective role of zinc in nickel induced hepatotoxicity in rats. Chemico-Biological Interactions 2004; 150: 199-209.
23. 131I uptake, its clearance, and circulating levels of triiodothyronine and thyroxine in leadtreated rats. Radtat Environ Biophys 1999; 38: 261-266.
24. 65Zn in different organs of rats following nickel toxicity. Biol Trace Element Res 2004; 102: 173-188.
25. Wallech DFH, Kamat VB. Separation of plasma membrane fragments from mouse ascites tumor cells. Methods in Enzymol 1966; 3: 16-21.
26. Behne D, Kyriakopoulos A, Meinhold H, Kohrle J. Identification of type I iodothyronine 5 - deiodinase as selenoenzyme. Biochem Biophys Res Commun 1990; 173: 1143-1149.
27. Bellabarba D, Benard B, Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotropin after treatment of thyrotoxicosis. Clin Endocr (Oxf) 1972; 1: 345-349.
28. Shalet SM, MacFarlance IA, Beardwell CG. Patient at risk of hypothyroidism. Lancet 1977; 2: 1356-1357.
29. 131I uptake, its clearance and circulating levels Rad Environ Biophys 1999; 38: 261-266.
30. Licastro F, Mocchegiani E, Zannotti M et al. Zinc affects the metabolism of thyroid hormones in children with Down's syndrome: Normalization of thyroid stimulating hormone and of reversal triiodothyronine plasmic levels by dietary zinc supplementation. Intern J Neuroscience 1992; 65: 259-268.
31. Arreola F, Paniagua R, Perez A. Effect of zinc treatment on the serum thyroid hormones in uremic patients under peritoneal dialysis. Horm Metab Res 1993; 25: 539-542.
32. Larsen LG. Studies on radioiodine treatment of thyrotoxicosis with special reference to the behavior of the radioiodine tracer tests. Acta Radiol 1955; 126-135
33. Tubiana M, George J, Doroszewski J, Antic M. Evolution de la fonction thyrodienne de rats irradies a 1 'iode 131. Ann Radiol 1961; 4: 731-740.
34. Jeevanram RK, Shah DH, Sharma SM, Ganatra RD. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patient. Int J Rad Appl Instrum Part B, 1986; 13: 277-279.
35. 125I isotope of iodine in the rat. J Endocrinol 1976; 71: 109-114.
36. Lovell MA, Xie C, Markesbery WR. Protection against amyloid beta peptide toxicity by zinc. Brain Res 1999; 823: 88-95.
37. Bellabarba D, Benard B, Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotropin after treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 1972; 1: 345-349.
38. Nishiyama S, Futagoishi Y, Suginohara Y et al. Zinc supplementation after thyroid hormone metabolism in disabled patients with zinc deficiency. J Am Coll Nutr 1994; 13: 62-67.
39. Kralik A, Eder K, Kirchgesser M. Influence of zinc and selenium deficiency on parameter relating to thyroid hormone metabolism. Hormone Metabolic Res 1996; 28: 223-226.